Cronos Group Inc. (CRON) stock
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/307% below fair value
$3.38−0.03 (-0.88%)
Close on Nov 13, 2026Market cap $1.25BP/E 19.9Yield –
Cronos total assets
Total assets on the balance sheet at the end of each period.
Cronos's total assets was $1.20B at Sep 30, 2026. For fiscal 2025 it was $1.20B, up 2.6% from the year before. The highest annual figure on record is $2.09B in fiscal 2019.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.20B | +2.6% |
| FY2024 | Dec 31, 2024 | $1.17B | +2.3% |
| FY2023 | Dec 31, 2023 | $1.14B | -6.0% |
| FY2022 | Dec 31, 2022 | $1.21B | -13.2% |
| FY2021 | Dec 31, 2021 | $1.40B | -27.4% |
| FY2020 | Dec 31, 2020 | $1.93B | -7.9% |
| FY2019 | Dec 31, 2019 | $2.09B | +1039.4% |
| FY2018 | Dec 31, 2018 | $183.47M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.20B | +1.7% |
| Q2 FY2026 | Jun 30, 2026 | $1.18B | +0.4% |
| Q1 FY2026 | Mar 31, 2026 | $1.17B | +1.6% |
| Q4 FY2025 | Dec 31, 2025 | $1.20B | +2.6% |
| Q3 FY2025 | Sep 30, 2025 | $1.18B | -0.5% |
| Q2 FY2025 | Jun 30, 2025 | $1.18B | +7.7% |
| Q1 FY2025 | Mar 31, 2025 | $1.15B | +4.1% |
| Q4 FY2024 | Dec 31, 2024 | $1.17B | +2.3% |
| Q3 FY2024 | Sep 30, 2024 | $1.18B | +3.0% |
| Q2 FY2024 | Jun 30, 2024 | $1.09B | -6.6% |
| Q1 FY2024 | Mar 31, 2024 | $1.11B | -4.4% |
| Q4 FY2023 | Dec 31, 2023 | $1.14B | -6.0% |
| Q3 FY2023 | Sep 30, 2023 | $1.15B | -7.1% |
| Q2 FY2023 | Jun 30, 2023 | $1.17B | -12.3% |
| Q1 FY2023 | Mar 31, 2023 | $1.16B | -15.4% |
| Q4 FY2022 | Dec 31, 2022 | $1.21B | -13.2% |
| Q3 FY2022 | Sep 30, 2022 | $1.24B | -19.4% |
| Q2 FY2022 | Jun 30, 2022 | $1.33B | -16.9% |
| Q1 FY2022 | Mar 31, 2022 | $1.37B | -27.1% |
| Q4 FY2021 | Dec 31, 2021 | $1.40B | -27.4% |
| Q3 FY2021 | Sep 30, 2021 | $1.54B | -20.0% |
| Q2 FY2021 | Jun 30, 2021 | $1.60B | -16.1% |
| Q1 FY2021 | Mar 31, 2021 | $1.88B | -2.4% |
| Q4 FY2020 | Dec 31, 2020 | $1.93B | -7.9% |
| Q3 FY2020 | Sep 30, 2020 | $1.92B | +945.9% |
| Q2 FY2020 | Jun 30, 2020 | $1.91B | – |
| Q1 FY2020 | Mar 31, 2020 | $1.93B | – |
| Q4 FY2019 | Dec 31, 2019 | $2.09B | – |
| Q4 FY2018 | Dec 31, 2018 | $183.47M | – |
See a number that looks wrong?